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LINE-1 repeats account for ∼17% of the human genome. Little is known about their individual methylation
patterns, because their repetitive, almost identical sequences make them difﬁcult to be individually targeted.
Here, we used bisulﬁte conversion to study methylation at individual LINE-1 repeats. The loci studied
included 39 X-linked loci and 5 autosomal loci. On the X chromosome in women, we found statistically sig-
niﬁcant less methylation at almost all L1Hs compared with men. Methylation at L1P and L1M did not correlate
with the inactivation status of the host DNA, while the majority of L1Hs that were possible to be studied lie in
inactivated regions. To investigate whether the male–female differences at L1Hs on the X are linked to the
inactivation process itself rather than to a mere inﬂuence of gender, we analyzed six of the L1Hs loci on
the X chromosome in Turners and Klinefelters which have female and male phenotype, respectively, but
with reversed number of X chromosomes. We could conﬁrm that all samples with two X chromosomes are
hypomethylated at the L1Hs loci. Therefore, the inactive X is hypomethylated at L1Hs; the latter could play
an exclusive role in the X chromosome inactivation process. At autosomal L1Hs, methylation levels
showed a correlation tendency between methylation level and genome size, with higher methylation
observed at most loci in individuals with one X chromosome and the lowest in XXY individuals. In summary,
loci-speciﬁc LINE-1 methylation levels show considerable plasticity and depend on genomic position and
constitution.
INTRODUCTION
Repetitive DNA sequences constitute about half of the non-
coding DNA or 45% of the human genome (1). Long and
short interspersed elements (LINEs and SINEs) constitute
the majority of these repeats, accounting together for  33%
of the genome (1). LINE-1 and Alu repeats are the major
LINEs and SINEs; they make up  17 and 11% of the total
DNA, respectively. About 0.5 and 1.1 million copies of
LINE-1 and Alu exist in the haploid human genome, playing
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Advance Access published on October 4, 2011an important role in the overall architecture and organization
of the genome. LINE-1 sequences are 2-fold enriched on the
human X chromosome compared with autosomes (2). More-
over, LINE-1 sequences have been proposed to play a role
in the X chromosome inactivation process by either spreading
or maintaining the inactivation state (3). The complete human
LINE-1 sequence consists of  6 kb that harbor two genes,
open reading frame 1 and 2 (ORF1 and ORF2), coding for
40 and 150 kDa proteins that act as a nucleic acid chaperone
with endonuclease and reverse transcriptase activities (4–6).
These protein properties enable LINE-1 sequences to mobilize
themselves together with other sequences (such as Alu) within
the human genome, thus making it the only known active mo-
bilizing machinery in the human genome (7).
It is believed that  8000–10 000 full-length LINE-1
(.6 kb) copies exist in the human genome. Most LINE-1
repeats are unable to induce retrotransposition events, either
because they have been mutated in critical sequences, are trun-
cated, or because they carry rearranged sequences. It is esti-
mated that only  80–100 copies of LINE-1 are still active
today in the diploid human genome (8,9). LINE-1 sequences
contribute to the variability of the human genome and to inter-
individual differences by variations in their insertion sites
(presence or absence at a given site) and by their expression
status which is proposed to inﬂuence gene expressions of
neighboring genes and of host genes as has been recently sug-
gested (10). In providing evidence for the polymorphic inser-
tions, recently, four independent studies, using genome-wide
sequencing approaches, provided data for the polymorphic
occurrence of LINE-1 repeats in the human genome; their
estimate of the occurrence of the polymorphic insertions
ranged between 5 and 285 events per genome (11–14). On
the other hand, the expression potential of a given LINE-1
element is determined in itself by two factors: the sequence
and polymorphisms of the repeat (i.e. the degree of homology
to the full-length expressed LINE-1) and the methylation epi-
genetic status of the promoter region of the repeat (10,15,16).
In other words, it may not be sufﬁcient to know the sequence
and the position of a given LINE-1 repeat to predict its expres-
sion. Knowledge about its epigenetic/methylation status would
also be necessary.
The majority of the LINE-1 promoter regions, whether
present in full-length or truncated LINE-1, are believed to
be heavily methylated at their cytosines in a CpG dinucleotide
context. This phenomenon is believed to be a cellular defense
system to repress the expression and, therefore, to silence the
retrotransposition activities of LINE-1 (15,16). However, vari-
ability of global LINE-1 methylation is frequently observed in
different tumors and by speciﬁc environmental or life style
conditions (17–19). In addition, we found that gender is an
important factor inﬂuencing global LINE-1 methylation,
while neither natural hormone cycles nor age has a large inﬂu-
ence on LINE-1 DNA methylation in leukocytes (20,21).
Although plenty of data exist on average genome-wide
LINE-1 methylation levels in healthy and diseased human
tissue, only a small number of studies has addressed methyla-
tion levels at individual LINE-1 loci in healthy individuals to
date. This is mainly due to their repetitive and abundant nature
in the genome, which makes measuring of methylation levels
and patterns of individual LINE-1 repeats a challenge.
To date, Phokaew et al.( 22) have provided the only detailed
study directly analyzing methylation at locus-speciﬁc LINE-1
repeats in a quantitative manner. They studied 17 full-length
autosomal loci in four different cell types. The authors
found cell type as well as locus-speciﬁc variations. Only a
limited number of studies on genome-wide methylation ana-
lysis using bisulﬁte deep sequencing could map a number of
locus-speciﬁc LINE-1 repeats (based on existing polymorph-
isms in speciﬁc individual repeats) (23,24). However, only
speciﬁc cell types were analyzed, such as ES cell lines, prim-
ordial germ cells or ﬁbroblast cell lines, and their methylation
results are far from being quantitative at speciﬁc loci.
In addition, none of these studies compared X-linked with
autosomal LINE-1 loci.
Therefore, a study on both autosomal and X-linked locus-
speciﬁc LINE-1 loci using a highly quantitative method
from healthy blood tissue of a large number of individuals is
still lacking. To this end, we used bisulﬁte analysis combined
with semi-nested polymerase chain reaction (PCR) followed
by highly quantitative methods to measure methylation at
individual LINE-1 sequences. We addressed the inﬂuence of
inter-individual variations and the effect of genomic position
and chromosomal constitution on the level of methylation in
a large number of individuals, including Turner syndrome
patients (45,X), healthy male (46,XY), healthy female
(46,XX) and Klinefelter syndrome patients (47,XXY). Our
analysis revealed three novel observations. First, a consider-
able variability in the level of methylation at different loci
and between different individuals at some loci was observed.
Secondly, L1Hs subtype in X chromosomal regions that are
subject to inactivation are signiﬁcantly less methylated on
the inactive allele, while L1P are similarly methylated at
both active and non-active X and in both inactivated and
non-inactivated regions. Thirdly, a tendency towards higher
methylation at autosomal LINE-1s in smaller genomes
(Turner syndrome versus Klinefelter syndrome) was observed,
suggesting limited methylation capability within cells that
could be depleted faster in bigger genomes and/or in rapidly
dividing cells such as the studied blood-derived leukocytes.
RESULTS
Individual LINE-1s are heavily methylated, but show
loci-speciﬁc variation as well as inter-individual
variations but only at some loci
We studied 44 speciﬁc LINE-1 loci with 39 (15 L1Hs, 8 L1M,
16 L1P) on the X chromosomes and 5 (L1Hs) on different
autosomes. The ﬁrst noticeable characteristic of all studied
LINE-1 CpGs was high methylation regardless of whether
autosomal or X-linked (Fig. 1A). However, considerable inter-
loci and inter-individual variability were seen, speciﬁcally at
some and not all loci (Fig. 1B and Supplementary Material,
Table S1).
For example, the average methylation level at the autosomal
loci in the male and female groups showed a range of 63%
(C2Hs-CpG3) to 99% (C6Hs-CpG3) (Supplementary Material,
Table S1). At the X-linked studied regions, L1Hs showed a
wider range of methylation between different loci, with a
range of as low as 30% (CXHs7-CpG2) to 100% (CXHs12-
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100% (several loci); and L1M loci were considerably less
methylated with a range of 21% (CXM4-CpG2) to 90%
(CXM2-CpG2).
Most importantly, variability in methylation was not only
observed between different CpG sites but also between dif-
ferent individuals at a given CpG site. This inter-individual
difference could be reﬂected by the variance parameters,
which showed that some CpGs could harbor wider inter-
individual differences than other loci which are more
stable in their methylation among the population
(Fig. 1B and Supplementary Material, Table S1). The
reason why only few loci showed large variability so that
we deﬁned them as hyper-variable loci with a variance of
above 100, while others are more stable, is not known.
Notably, local C to T polymorphisms are absent from
these loci (at least from three regions that we sequenced
in all individuals: C2Hs, C10Hs and C11Hs). Hence, such
single nucleotide polymorphisms (SNPs) presence/absence
does neither cause nor contribute to these inter-individual
differences at the hyper-variable loci. However, polymorph-
isms in the surrounding sequences that would affect the
methylation levels at these loci, as previously observed at
non-repetitive elements, cannot be excluded (25,26). Thus,
we distinguish C2Hs on autosomes as the hyper-variable
region and CXHs1, CXP4, CXP9, CXP13, CXM6 and
CXM7 on the X chromosome (Fig. 1B and Supplementary
Material, Table S1). In summary, variability of methylation
levels was observed in two dimensions, namely between dif-
ferent loci and between individuals.
Figure 1. Heat map presentations of (A) the average of methylation and (B) the variance of methylation at the studied LINE-1 loci. Linear scale is used to
represent the data.
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equally methylated at both Xi and Xa at L1P
and variable at L1M
We studied three major LINE-1 subtypes on the X chromo-
some in two groups of healthy males and females: namely
L1Hs, L1M and L1P. We restricted our analysis to full-length
LINE-1 (.6 kb). Thus, we could ﬁnd 25 L1Hs loci on the
X chromosome (UCSC RepeatMasker table). We designed
speciﬁc assays for all of the 25 loci, However, 10 of them
were either impossible to analyze speciﬁcally because of the
absence of loci-speciﬁc ﬂanking sequences in close range of
500 bases upstream of the start of the repeat sequence or
because the quality and sequence speciﬁcity did not pass our
quality criteria. The remaining 15 loci were distributed as
follows: 8 in directly strongly inactivated gene/loci (escaping
score of 1 or 2) and 7 in moderately inactivated loci (inactiva-
tion score 3–7). No full-length L1Hs were present in strong
non-inactivated (escaping) genes/loci (Fig. 2 and Supplemen-
tary Material, Table S2). At 14 of these loci, male samples
were methylated higher than female samples, of which 12
are statistically signiﬁcant. At only one loci, CXHs8, which
has the highest escaping score of 7, equal methylations
between male and female were observed. As women have
one inactivated X, we supposed that this reduction in methyla-
tion in female samples is derived from this inactive X. Thus,
we assumed that these loci are hypomethyled at the inactive X.
Among the second category of LINE-1, L1M, we identiﬁed
50 full-length copies and we designed assays for 14 of them
and 8 of these passed our quality control. Two of the loci
were in escaping gene/loci (escaping score 8) and three in
inactivated gene/loci (escaping score 2), while the rest were
in moderately inactivated gene/loci (escaping score 7). Four
of the loci were highly methylated in males, one being statis-
tically signiﬁcant, and equally, four loci were highly methy-
lated in females and, again, only one was statistically
signiﬁcant. Thus, at the studied L1M loci, we found a mixed
picture of higher methylation at the Xi or Xa with no clear
correlation to the inactivation status of the underlying locus.
At the third category, which is the most abundant at the X
chromosome with 737 full-length copies, we designed assays
for 24 different regions, 16 of which passed our quality
control. These loci were divided into two groups: the ﬁrst
group includes 11 L1P loci in inactivated gene/loci (escaping
score of 1–2), while the second group includes six loci in
escaping gene/loci. We found that, on average, most loci are
slightly more methylated in males, while four are slightly
more methylated in females. The difference between male/
female methylation was signiﬁcant only at CXP5. Therefore,
from the studied loci, it seems that L1P sequences are not
largely differentially methylated between Xa and Xi as
observed at the L1Hs sequences. Therefore, the relatively
strong hypomethylation on the inactivated regions may be
more restricted to L1Hs promoter regions.
Next, we wanted to investigate whether the differences
between males and females at the L1Hs loci are indeed stem-
ming from the inactivated X or whether these are gender-
speciﬁc differences induced by sex differences such as
hormones. Thus, we analyzed six X-linked L1Hs (Fig. 2,
underlined) that showed the highest differences between
males and females in a group of Turner and Klinefelter indivi-
duals who are physiologically and phenotypically female and
male, respectively. However, Turners have only one active X,
while Klinefelters have two Xs with one active and one in-
active like a typical female. Indeed, a pair-wise comparison
of a group of samples with one X chromosome (46,XY male
samples and 45,X Turner samples) and samples with two X
chromosomes and one inactivated X (46,XX female samples
and 47,XXY Klinefelter samples) shows a signiﬁcant drop
of methylation at all loci in genomes with two X chromosomes
(Fig. 3 and Supplementary Material, Table S1). Therefore, we
assumed that this difference is not speciﬁc for female versus
male samples since Klinefelter versus Turner showed a
similar signiﬁcance with the Klinefelter group being hypo-
methylated. Moreover, the differences are speciﬁc for the X
chromosome as all studied LINE-1 CpG sites at autosomes
were not differentially methylated between different groups
of samples (Supplementary Material, Table S1).
Bisulﬁte sequencing of individual PCR products from three
regions (CXHs15, CXHs13 and CXHs6) clearly conﬁrmed the
quantitative data and provided a clear picture on the nature of
the difference between the active and inactive X chromosome
at such regions (Fig. 4A). Two major facts can be observed:
(i) the presence of a second X chromosome (supposedly inac-
tivated) clearly reduces average methylation at all three loci
indicating that the inactive X is hypomethylated at these
repeats. (ii) This hypomethylation is largely non-allelic in its
nature as the methylated and non-methylated CpG sites do
not cluster in nearly completely methylated and non-
methylated clones as observed at differentially methylated
regions associated with imprinted genes. The difference in
occurrence of methylation between the two groups of
samples (with one X and with two Xs) as tested by the non-
parametric Wilcoxon test was signiﬁcant with P-values ,
0.0001 for all three regions. Additionally, the methylation
entropy was calculated for all samples at every region, reveal-
ing a clear-cut between the samples with one X (entropy
,0.280) and those with multiple Xs (entropy .0.507)
(Fig. 4A). Thus, the effect of the presence of inactivated X
on the entropy was even more pronounced than what is seen
with the average methylation differences.
We further investigated selected loci on X-linked inacti-
vated regions (CXHs15, CXHs3 and CXHs10) in lymphoblas-
toid and ﬁbroblastoid cell lines with different X chromosome
counts (Supplementary Material, Table S3). Clear negative
correlations of X chromosome number and methylation
levels in each cell line were observed at CXHs15 and
CXHs10. This indicates that the hypomethylation phenom-
enon is not only restricted to blood cells, but that it is a
more general phenomenon present in lymphoblastoid as well
as ﬁbroblastoid cell lines.
Methylation levels on the X chromosomes in 47,XXY
Klinefelter samples are reduced in comparison to 46,XX
female samples
A direct comparison between female and Klinefelter samples
revealed distinctly higher methylation in female samples at
several X-linked LINE-1-inactivated regions (Fig. 3 and Sup-
plementary Material, Table S1). This higher methylation was
222 Human Molecular Genetics, 2012, Vol. 21, No. 1Figure 2. Relative positions of the full-length (.6 kb) L1Hs, L1P and L1M on the X chromosome. The studied regions in this study are labeled with dashed line.
Expression data from Carrel and Willard (57) are presented in the ﬁrst column, where scale of expression is 0–9 (number of cell lines with inactive X that were
expressing a given gene); we empirically considered score of 0–2 to be inactivated (red), 3–6 to be middle inactivated (green) and 8–9 escaping inactivation
(blue). In the second, third and forth columns are the L1Hs, L1M and L1P full-length copies (.6 kb) represented by dots. An inactivation score for every locus
was empirically calculated according to the position of the LINE-1 sequence relative to the studied transcripts represented in column 1, thus a 1 score is given for
a locus in a gene that is inactivated, 2: between two inactivated genes, 3: between one inactivated gene and one middle inactivated gene, 4: between one inacti-
vated gene and one non-inactivated gene, 5: between two middle inactivated genes, 6: in a middle inactivated gene, 7: between one middle inactivated gene and
non-inactivated gene, 8: between two non-inactivated gene, 9: in a gene that is non-inactivated. The inactivation score is given right to the given studied L1 dot,
followed by the male–female average methylation difference, followed by the name of the loci. The statistically signiﬁcant difference between the males and
females is labeled with a star. The underlined loci represent the ones studied in all four groups of samples.
Human Molecular Genetics, 2012, Vol. 21, No. 1 223observed at all CpG sites except CXHs13-CpG2 and it was stat-
istically signiﬁcant at all CpG sites of CXHs15 and CXHs3 as
well as CpG1 of CXHs10. Cloning and sequencing data
largely conﬁrm the existence of this phenomenon at CXHs15
and CXHs6 loci but not at CXHs13 (Fig. 4A), which is consist-
entwiththequantitativedata.Moreover,atoneofthesixstudied
CpG islands (CX0) subject to X chromosome inactivation, a
statistically signiﬁcantly higher methylation in female samples
Figure 3. Box plots summarizing methylation levels at six L1Hs X-linked loci in inactivated regions and middle inactivated regions. Blue, light blue, pink and
red boxes represent Turner (T), male (M), female (F) and Klinefelter (K) samples, respectively. Statistical signiﬁcance is represented above each box with stars
and connecting lines; each star corresponds to a signiﬁcant P-value of E-10.
224 Human Molecular Genetics, 2012, Vol. 21, No. 1Figure 4. Summary of bisulﬁte sequencing results. (A) Three X-linked loci (CXHs15, CXHs13 and CXHs6) and (B) three autosomal loci (C2Hs, C11Hs and
C20Hs) in Turner (45,X), male (46,XY), female (46,XX), Klinefelter (47,XXY) samples and one Klinefelter sample with a 49,XXXXY karyotype. Equal
amounts of DNA from three individuals were pooled together prior to bisulﬁte treatment, PCR products were cloned into a TA cloning vector and large
numbers of individual clones were sequenced. Individual CpGs are represented as blue ﬁlled and yellow ﬁlled circles representing methylated and unmethylated
CpGs, respectively. Average methylation of all CpGs in all sequenced clones in a given region is provided under each group of clones. Vertical arrows indicate
the positions of the CpGs studied by SIRPH or pyrosequencing reaction.
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Table S1). Several factors could explain these differences
among which is the possibility that the inactivation process
may differ slightly between 46,XX and 47,XXY possibly due
to factors on X or Y affecting the inactivation process. A
second explanation could be the larger genome size in
47,XXY cells that would leave less methylation capacity at in-
dividual LINE-1 sites, while a third possibility is the hormonal
differences between females and Klinefelters, with the latter
having therapeutic male levels of hormones.
A tendency for inverse correlation of methylation
at autosomal LINE-1 with genome size is observed
We studied autosomal LINE-1 methylation at ﬁve different
loci on chromosomes 2, 6, 10, 11 and 20 in the four groups
of samples: Turners, males, females and Klinefelters. These
loci cover 14 different CpG sites that occur at the promoter
region of L1Hs consensus sequence. In contrast to the
X-linked inactivated L1Hs regions, there was no statistically
signiﬁcant difference between any two groups of the studied
Fig. 4 Continued
226 Human Molecular Genetics, 2012, Vol. 21, No. 1samples at the 14 studied autosomal CpG sites (Supplementary
Material, Table S2).
Nevertheless, an unexpected but a clear tendency was
observed at the autosomal CpG sites. When we plotted the
average methylation from every group in the order of increas-
ing genome size (i.e. number of nucleotides in each genome
with Turner samples as 100% reference genome size, male
samples: 101.00%, female samples: 102.62% and Klinefelter
samples: 103.63%), we could observe a clear correlation
(Fig. 5 and Supplementary Material, Table S4). The relatively
smallest genome in Turner (reference of 100%) samples
showed the highest methylation. This average methylation
decreased in a proportional manner towards the Klinefelter
samples (size 103.62% relative to Turner samples), which
harbor the biggest genome group of samples studied here.
We calculated Pearson correlation of the average methylation
at each site in every group with genome size as estimated from
the nucleotide bases in every chromosome (UCSC). Most of
the correlations (10 out of 12) were inversely proportional
to genome size with r-values ranging from 20.24
(C2Hs-CpG5) to 20.99 (C20Hs-CpG1), with the exception
of C6Hs-CpG1 and C10Hs-CpG1 with positive but weak cor-
relations (Fig. 5 and Supplementary Material, Table S4). In
addition, similar results were obtained when correlation with
either the CpG numbers in a genome or the number of X
chromosome were tested (Fig. 5). Albeit, correlations were
highest with genome size (nucleotide number) followed by
number of CpGs in a given genome, followed by number of
present X chromosomes.
Yet, a strong positive correlation between average methyla-
tion levels of the four groups and genome size was observed
at CpG3 and CpG6 of C2Hs (Supplementary Material,
Table S4). One common feature between both of these CpGs
is that they 3′ ﬂank directly another CpG site. To investigate
the possibility of experimental artifacts that could have been
introduced by using one pyrosequencing reaction with a single
sequencing primer to read all six CpGs in the C2Hs region, we
designed one sequencing primer for every CpG site. We
observed that CpGs 1, 2, 4 and 5 show similar tendencies with
allprimersets,whileCpGs3and6werenotconsistentwithdif-
ferentprimers.Therefore,weexcludedthelattertwoCpGsfrom
this evaluation (Supplementary Material, Fig. S1).
In addition to the above four sample groups, when we added
methylation values of an available single DNA sample with
the karyotype of 49,XXXXY [samples show a considerable
drop of autosomal LINE-1 methylation at most CpG sites
compared with all other groups (Supplementary Material,
Table S4)] as a ﬁfth point of measurement, stronger r-values
for correlation between methylation levels and genome size
at most CpG loci were observed, namely at C2Hs (CpG2,
CpG4, CpG5), C6Hs (CpG1, CpG2), C10Hs (CpG1) and
C11Hs (CpG1) (Supplementary Material, Table S4; Fig. 5
versus Supplementary Material, Fig. S2). This strengthens
the hypothesis that increasing genome size will further
reduce methylation at individual CpG sites in LINE-1 pro-
moter regions in peripheral blood-derived DNA.
To further validate and visualize the highly quantitative
SIRPH (SNuPE combined with Ion paired Reverse Phase
HPLC) and pyrosequencing results, we performed extensive
sequencing of individual PCR strands from three autosomal
regions, C2Hs, C11Hs and C20Hs (Fig. 4B). For this analysis,
we grouped three DNA samples in equal proportions from
every group, with the exception of 49,XXXXY sample
where only one sample is available. At the two loci C11Hs
and C20Hs, where quantitative methylation results showed a
4–5% gradual decrease from Turner samples to Klinefelter
sample of 49,XXXXY, only minor differences between the
groups were observed [statistical comparison of the group of
samples with one active X (45,X and 46,XY) and the group
of samples with two Xs (46,XX and 47,XXY) by Wilcoxon
test gave non-signiﬁcant P-values of 0.8643 and 0.0907 for
C20Hs and C11Hs, respectively]. The only statistically signiﬁ-
cant detectable differences in the average methylation were at
C2Hs between Turner/male samples and female/Klinefelter
samples (signiﬁcant P-value of 0.0261). In fact, at the C2Hs
locus, quantitative methylation data showed a distinct
gradual decrease in methylation from the smaller genome to
the largest (Supplementary Material, Table S1). Sequencing
data also conﬁrmed these differences. Especially female
(91% methylation average) and Klinefelter samples (85 and
88%) showed a considerable drop compared with male and
Turner samples (97% each) (Fig. 4B). Interestingly, differ-
ences in methylation largely stem from allelic methylation
pattern, whereby some clones are completely unmethylated.
This allelic methylation resulted in a relatively lower methyla-
tion entropy than if a random (non-deterministic) distribution
of unmethylation were present. This was signiﬁcant at several
4-CpGs windows within the three samples with two or four X
chromosomes at the C2Hs locus (data not shown). This is a
clear indication of an allelic unmethylation.
Next, we investigated whether we could see this genome
size effect also in methylation of autosomal LINE-1 in ﬁbro-
blastoid and lymphoblastoid cell lines used in the above
section. Although hypomethylation associated with the
number of X chromosome was clearly seen, none of the auto-
somal LINE-1 loci (C2Hs, C10Hs and C11Hs) showed signiﬁ-
cant correlation with genome size (after correction for
multiple testing). The discrepancy between blood-derived
data and cell lines could be due to either the lower sample
number of the cell lines (thus less statistical power of detec-
tion) or to the differences between in vivo and in vitro cell
culture conditions. In this study, cells were cultured in
Dulbecco’s modiﬁed Eagle medium (DMEM) or Rosewell
Park Memorial Institute (RPMI) mediums providing unrestricted
supply of nutrients and methyl group donors.
Correlations of methylation levels between different
CpG sites
The wide distribution of studied CpGs in different LINE-1
enabled us to investigate whether a correlation of methylation
levels exists between different CpGs located at different chro-
mosomes, possibly suggesting a genetic or environmental
inﬂuence on levels of LINE-1 methylation genome-wide.
Therefore, we tested the correlations at the autosomal and
X-linked LINE-1 at L1Hs loci, and the X-linked CpG
islands that were studied in all four groups of samples.
Hence, we examined for (i) speciﬁc correlation of methylation
of CpGs within one L1Hs LINE-1 locus (intra-loci correla-
tions), (ii) correlation between CpGs of different L1Hs
Human Molecular Genetics, 2012, Vol. 21, No. 1 227Figure 5. Correlation of average methylation levels of autosomal LINE-1 and genomic size parameters. (A) With number of X chromosomes, (B) with relative
percentage of CpG numbers, (C) with relative percentage of nucleotides. Blue, light blue, pink and red ﬁlled circles represent Turner, male, female and Kline-
felter samples, respectively. Pearson correlation value is given for each correlation.
228 Human Molecular Genetics, 2012, Vol. 21, No. 1LINE-1 loci (inter-loci correlations), and (iii) correlations
between LINE-1 CpGs and non-LINE-1 CpGs.
At many LINE-1 loci, strong positive and some sporadic
negative correlations within each of the studied loci were
observed in Turner, male, female and Klinefelter samples
(intra-loci correlations) (data not shown). Also, positive as
well as negative correlations between different loci were
observed (inter-loci correlations) (P-values ,0.05); after cor-
rection for multiple testing only few inter-loci correlations
remained signiﬁcant (data not shown). In addition, age did
not correlate with methylation at any of the studied loci
(data not shown).
The absence of statistically signiﬁcant widespread correla-
tions between different LINE-1 loci indicates that this vari-
ability may not be controlled by a genetic factor affecting
all repeats simultaneously. Instead, they may be inﬂuenced
by loci-speciﬁc factors as local nearby polymorphisms and/
or environmental factors, which could control methylation
levels separately at each individual locus. Also, we cannot
exclude the possibility that the stringent corrections for mul-
tiple testing (i.e. relatively high number of tests performed)
and the relatively low number of sample size are responsible
for the low power of detection of such correlations. Moreover,
the absence of correlations in the female and Klinefelter
samples at the severely hypomethylated L1Hs loci indicates
that this hypomethylation affects different loci at the inactive
X to different degrees and thus suggests that this is a rando-
mized process.
DISCUSSION
Repetitive elements, like the LINE-1 subfamily, are known to
be hypomethylated in tumors and their methylation levels are
affected by environmental factors (17,19,27,28). Hypomethy-
lation of speciﬁc LINE-1 could also activate alternative tran-
scripts of neighboring genes as in the case of MET oncogene
in bladder tumors or different cancer cell lines (29,30). In add-
ition, we and others have previously shown that men have
slightly higher methylation levels than women, a fact that
became signiﬁcant when comparing about 96 samples from
every group (20,21,31,32). We also recently proved that the
gender difference in the methylation of LINE-1 is not
induced by male/female hormone differences (21). Moreover,
the involvement of the LINE-1 elements and consequently
their methylation is strongly suggested in the X chromosome
inactivation process either by initializing, promoting or main-
taining the inactivation process (3).
Variability of methylation at individual LINE-1
Detailed data on inter-individual variability of methylation at
individual LINE-1 from total blood in large number of
healthy individuals have not been studied sufﬁciently. In
fact, using a degenerate assay to measure global LINE-1
methylation at promoter regions, we identiﬁed a considerable
variability in male and female blood-derived DNA (21). More-
over, tissue-speciﬁc differences have been reported (33).
However, only one report described in detail loci-speciﬁc
methylation patterns at 17 different LINE-1 loci in several
cell types, including different tumor cell lines but only 12
samples of normal oral epithelium (22). In contrast, no
report dealt with inter-individual differences in a large
cohort of blood samples derived from healthy individuals or
with different types of aneuploidy using a highly sensitive
method to measure subtle methylation differences. Our data
presented here provide evidence for three types of variability
in methylation at LINE-1-speciﬁc loci. The ﬁrst type is the
inter-loci variability. Although most loci were heavily methy-
lated, there were some considerable inter-loci variations. The
second type of variability was observed in different CpGs on
the same locus (intra-loci variations). Both of these variation
types, inter- and intra-loci variation, could be induced by spe-
ciﬁcity of DNMT3A and DNMT3B, which preferentially
methylate speciﬁc CpGs at non-repeats, dependent on the
underlying DNA sequence (34). Yet, evidence that this
could also be the case for LINE-1 repeats is still lacking.
Both of the above variations have been previously known
and reported by others in several studies. However, the third
and most signiﬁcant of the observed variations that have not
been discussed sufﬁciently in the literature is the inter-
individual variation, which can be clearly seen by the variance
parameters of each locus (Fig. 1B and Supplementary Mater-
ial, Table S1). This was previously reported in a small number
of normal oral epithelium samples (22) but similar data in a
large cohort of healthy blood samples have been lacking. Con-
sidering the male and female groups, it was obvious that not
all loci are equally variable in their methylation but that
some minorities of loci are hyper-variable (deﬁned here as
variance .100) in both males and females (Fig. 1B). Only
two such loci were observed at L1Hs loci (CXHs1 and
C2Hs), while more hyper-variable loci were present at L1P
(CXP4, CXP9, CXP13) and L1M (CXM6, CXM7) subtypes.
Polymorphisms of mainly C to T at the investigated CpG
sites can cause high inter-individual variability. However,
this has been excluded by sequencing all samples in three
regions (C2Hs, C10Hs and C11Hs). This observed inter-
individual variability could still be due to other neighboring
polymorphisms that act in cis at a lower distance (25,26).
We cannot exclude this possibility. Moreover, this variability
could also be global, affecting several loci simultaneously or
genome-wide (35) due to genetic factors that act globally in
trans or as a result of environmental factors. However,
inter-CpG correlation analysis did not show signiﬁcant inter-
loci correlation. Thus, we assume that these variations are
random stochastic variations not resulting from global but
largely rather locus-speciﬁc factors.
Hypomethylation of LINE-1 at X-linked L1Hs inactivated
regions: cause or consequence of inactivation?
On the X chromosome, we investigated three groups of
LINE-1 subtypes: 15 L1Hs, 16 L1P and 8 L1M. In comparison
to males, female samples demonstrated considerable and sig-
niﬁcant hypomethylation at almost all L1Hs but not at L1P
or L1M (Fig. 2). However, most L1P loci were also higher
methylated in males, while the L1M loci particularly showed
a mixture of correlation to gender with four loci each more
methylated in males and females, respectively (Fig. 2). We
assume that the high order lowering of methylation at L1Hs
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chromosome. This clearly explains our previous results of a
signiﬁcant decrease in methylation in women at genome-wide
global LINE-1 5′ regions when using degenerate primers
based on the L1Hs promoter consensus sequence (20,21).
However, these results appear to be at odds with the observa-
tions made by Hansen (36), who concluded that both LINE-1
promoters on active as well as inactive chromosomes are
hypermethylated in normal cells, while a signiﬁcant hypo-
methylation on the inactive X in ICF cells is observed.
Although the conclusions from Hansen were largely correct
regarding hypermethylation of the studied loci on X chromo-
somes, the relatively small difference in the hypermethylation
between men and women was missed because—in contrast to
our analysis—the methods used were largely non-quantitative
(based on southern blots and bisulﬁte cloning and sequencing).
Yet, a close look at his data revealed clear indication of
healthy female hypomethylation in comparison to healthy
male samples and  12% lower methylation in female lym-
phoblastoid cells at one X-linked L1Hs [81.7% methylated
sites in male samples versus 69.7% in female samples using
the average of methylated sites from the cloning and sequen-
cing data of Hansen’s Figure 4 (36)].
To test whether hypomethylation of the LINE-1 regions is
speciﬁc for inactivated or non-inactivated (escaping) genes/
regions, we analyzed LINE-1 loci distributed on both inacti-
vated and non-inactivated regions of the X chromosome.
This was possible only for L1M and L1P loci but not for
L1Hs due to the absence of full-length L1Hs loci on the non-
inactivated (strongly escaping) regions. In the L1P group as
well as the L1M group, there was no clear association
between hypomethylation on the inactive X and the inactiva-
tion status of the host DNA (Fig. 2). Especially at the L1P,
the degree of hypomethylation on the inactive X was quite
similar between the inactivated and the escaping regions.
Apparently, the generalized severe hypomethylation of the in-
active X is not only restricted to the inactivated regions but
speciﬁcally so to L1Hs promoter regions that, in contrast to
other LINE-1 subtypes, contain higher density of CpGs
predicted to be a CpG island.
Since the hypomethylation at the L1Hs on the inactive X
chromosome could be a simple effect of hormone differences
rather than a cause or consequence of the inactivation, we ana-
lyzed six L1Hs regions showing the highest differences
between male and females in two cohorts of Turners
(hormone-wise female, but with only one active X) and Kline-
felters (hormone-wise male, but with two X chromosomes:
one active and one inactive). Indeed, all samples with two X
chromosomes showed this signiﬁcant hypomethylation
(Fig. 3), but not samples with one active X. Therefore, the
L1Hs hypomethylation on the Xi is linked to the X chromo-
some inactivation process or it is a consequence of the inacti-
vation status rather than a simple effect of hormonal
differences.
Previous methylation proﬁling of the X chromosome has
also shown differences between Xi and Xa in a sequence-
and region-speciﬁc manner. Most CpG islands show a clear
hypermethylation on the Xi as expected because of inactiva-
tion, while  7% showed a hypomethylation at the Xi (37).
Outside CpG islands, Xi was shown to be hypomethylated in
the gene bodies (38) and global hypomethylation of Xi was
also reported (39). Therefore, and based on our reported
results here, it seems that the methylation status of a given
CpG on the inactive X depends on many factors, such as
CpG density, sequence context (class of repeat) and relative
position to gene expression. However, a single base resolution
of methylation proﬁling of the Xi and Xa in different stages of
X chromosome inactivation is necessary to determine the
factors that rule the methylation status of a given X-linked
CpG site.
Involvement of the LINE-1 repeats in the X chromosome
inactivation process was suggested in 1998 by Lyon (40).
The mainstream theory is that LINE-1 elements could
work as boosters (or ‘way stations’ as termed by Gartler and
Riggs (41), yet without naming LINE-1 ‘stations’) for the
spreading of the inactivation signal or to maintain the
inactivation status. Since this ﬁrst hypothesis, several
studies have supported involvement of LINE-1 in the
process of X-inactivation, but none has provided a direct/
ultimate proof to date.
Density of LINE-1 on the X chromosome was found to be
double compared with autosomes (26.50 versus 13.43%),
while several other repeats, such as SINE, were not enriched
on the X (42). The highest density of LINE-1 enrichment is
on the Xq13, which contains the center of inactivation. More-
over, density of LINE-1 was higher on inactivated regions
than non-inactivated regions, escaping the inactivation
process (26.5 versus 10.3%) (42). Considering in more detail
Xp22, which contains both active and inactive genes, Carrel
et al.( 43) could show that the surroundings of inactive gene
regions are particularly enriched with sequences correspond-
ing to LINE-1 sequences which are otherwise underrepre-
sented on Xp22 in comparison to the inactivated regions of
the X chromosomes. A direct link between LINE-1 density
and effectiveness of inactivation comes from the X;autosomal
and autosomal;X translocations. These cases show that differ-
ent autosomal regions are not effectively/equally silenced
when translocated to the X (44,45). Reciprocally, when an
inducible Xist transgene is inserted into different mice auto-
somal loci, the silencing efﬁciency is determined by the
chromosomal domain organization of the integration locus
(46). Inactivation on autosomes is more effective in gene
poor and LINE-1 rich domains. Popova et al.( 47) also pro-
vided evidence that a LINE-1 poor region is able to attenuate
the primary inactivating Xist signal instead of failing to
maintain the inactivation status.
The strongest involvement of LINE-1 in the inactivation
process came from a recent mice study by Chow et al.( 48)
which showed that LINE-1 repeats participate in the inactiva-
tion process by creating with the Xist RNA a silent nuclear
compartment where inactivated regions are recruited to. More-
over, the youngest LINE-1 element families (Tf and Gf
LINE-1 in mice) are also transiently transcribed (from the
to-be-inactivated X) during the early inactivation process
(48). This LINE-1 expression is dependent on Xist expression
as well as facultative heterochromatin formation. Additionally,
the efﬁciency of Xist-mediated inactivation on mice autosomal
loci (in autosomal Xist transgenes) was correlated to the pres-
ence of full-length young LINE-1 elements (48). Therefore,
could L1Hs sequences in humans, which are exclusively
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on the inactive X and are absent from the non-inactivated loci,
correspond to Tf and Gf in mice and could they be also tran-
siently expressed during the inactivation process where their
expression is down regulating in cis the neighboring genes?
And could the hypomethylation of their 5′ promoter be a
mark of such earlier activity? Such data can be expected
from human ES cell studies. Although our data do not
provide a direct evidence for the involvement of L1Hs
sequences with the X chromosome inactivation process, still
we provide one more direct support for the likelihood of the
involvement of LINE-1 in the inactivation process in
humans, particularly L1Hs which are speciﬁcally and largely
hypomethylated on the inactive regions.
Methylation levels at speciﬁc LINE-1 and size
of the genome
In this study, we found an unexpected correlation between
genome size and methylation at autosomal LINE-1 promoter
elements. Several of the autosomal CpG sites showed a nega-
tive correlation between genome size as estimated from the
number of nucleotides in a given genome and methylation
levels (Fig. 5). The strongest negative correlation was
observed at C20Hs and C11Hs, while a positive correlation
was observed at C6Hs-CpG1 and C10Hs. The global
LINE-1 assay with degenerate primers did not show this ten-
dency (Supplementary Material, Table S1) probably due to
the insensitivity of the assay to variations at speciﬁc loci or
because only a subset of full-length L1Hs LINE-1 elements
studied here are showing this tendency.
However, the unexpected observation of a correlation
between genome size and methylation at autosomal LINE-1
promoter elements could also be explained by either presence
of a factor on the X chromosome that could induce hypomethy-
lation of the repeats or a limiting amount of a given factor
required for methylation of repeats. However, since the correl-
ation is strongest with genome size rather than X chromosome
count, the ﬁrst factor could be of lesser importance. What sup-
ports the second possibility is that, in a tissue culture system
where the nutrient factors—particularly the methyl donor—
are unlimited, no correlation between genome size and methy-
lation levels of LINE-1 CpG sites was found. Thus, our data
argue for a factor that is present in a limited amount so that
its deﬁciency effect is seen in either rapidly dividing cells
(like blood-derived cells) and/or in larger genomes. We
should acknowledge here that this phenomenon could be also
caused by differences in expression of gene(s) that could be
involved directly or indirectly with the methylation of
LINE-1 repeats. Such genes could be located at the X or even
the Y chromosome, for example on the X non-inactivated
regions,andthusexertadoseeffectdifferencesamongdifferent
groups of samples studied. An effect on gene expression
exerted by sex chromosome counts rather than sex was previ-
ously reported by Wijchers et al.( 49). Therefore, it is not unex-
pected that sex chromosome counts affect one of the epigenetic
layers that regulate gene expression.
In this study, using highly quantitative methylation analysis
of individual LINE-1 repeats, we showed that methylation is
not the same in all individuals and that it does not have the
same levels on all loci even when comparing the same cat-
egory of loci (autosomal or X-linked). In addition, we report
on a strong difference in methylation levels between active
and inactive X chromosomes with inactive ones considerably
hypomethylated (in the inactivated region) at the promoters
of full-length L1H regions. Finally, genome size affected
methylation levels at most autosomal loci with the lowest
methylation observed in the bigger genome.
MATERIALS AND METHODS
Blood samples and cell lines
Blood samples were collected from 22 female patients with
Turner syndrome (expected karyotype 45,X) and were
obtained from the Pediatric Endocrinology Division, Univer-
sity Children’s Hospital, Bonn, Germany. Forty men with Kli-
nefelter syndrome (expected karyotype 47,XXY) were
recruited to this study through the German Klinefelter associ-
ation, Falkenstein, Germany. In the latter group, two men were
reported to have 48,XXYY and 49,XXXXY karyotypes each.
In addition, control blood samples, matching in age with
Turner and Klinefelter samples, from 28 healthy men and 28
healthy women with a normal X chromosome count, matching
in age with Turner and Klinefelter samples, were collected
from blood donors at the Institute of Experimental Hematol-
ogy and Transfusion Medicine, Bonn, Germany. Furthermore,
a large sample group of young healthy men and women (96
each) with an average age of 23 + 3.46 years was also avail-
able to study inter-individual and inter/intra-loci variations.
All samples from all subjects were obtained upon written
informed consent. The local Ethics Committee of the Univer-
sity Clinics of Bonn approved the study (approval numbers:
106/05 and 121/06).
Several lymphoblastoid and ﬁbroblastoid cell lines with
essentially different X chromosome counts were used in this
study. These included: 45,X; 46,XY; 46,XX; 47,XXX;
48,XXXX; 49,XXXXY and 49,XXXXX lymphoblastoid cell
lines and 45,X; 47,XXX and 49,XXXXY ﬁbroblastoid cell
lines. All cell lines were in their early 20 passages. The ﬁbro-
blastoid cell lines were maintained in DMEM, 10% FCS,
2m M glutamine and Pen/Strep, while the lymphoblastoid
cell lines were incubated in RPMI, 10% FCS, 2 mM glutamine
and Pen/Strep. DNA from cell lines was extracted using the
DNeasy blood and Tissue kit from Qiagen (Hilden, Germany).
Chromosome copy number veriﬁcation
All Klinefelter and Turner blood samples as well as the cell
lines that we received were documented for their karyotypes
(especially X chromosome copy number). However, to
verify X chromosome copy number in Klinefelter and
Turner samples as well as in the cell lines and to determine
the mosaics rates (if any), we ﬁrst sequenced all samples at
six X-linked regions distributed over the whole X chromo-
some containing SNPs with a predicted high heterozygosity
in Caucasian populations (as reported in HapMap) (Supple-
mentary Material, Table S5, primers used to amplify these
regions are listed in Supplementary Material, Table S6).
Loss of heterozygosity at all markers would predict one X
Human Molecular Genetics, 2012, Vol. 21, No. 1 231and at least one heterozygous site would predict two X. To
predict the degree of cellular mosaicism, we applied a quanti-
tative pyrosequencing assay for ﬁve of the SNPs (primers are
listed in Supplementary Material, Table S6).
As a second method to quantitatively determine the copy
number of X chromosomes, a copy number assay from
Applied Biosystems was used. Brieﬂy, the assay consists of a
TaqMan minor groove binding probe labeled with FAM dye
and unlabeled PCR primers designed for the X-linked region
TCEAL4 not containing any copy number variations. The
assay was run simultaneously with a TaqMan
w Copy Number
Reference Assay (RNaseP using VIC
w dye-labeled
TAMRATM probes)inaduplexreal-timePCR.Relativequanti-
tation analysis of the target to the reference sequences was per-
formed by CopyCallerTM software, using a known calibrator
sample with two X chromosomes. Twenty nanograms of DNA
was used in a total reaction volume of 16 ml. The reaction mix
was prepared with the TaqMan Universal Master Mix. The
assay was performed in four replicates for all samples.
Klinefelter samples showed heterozygosity in at least one of
six markers in all samples except one (11 K). However, the
TaqMan-based copy number assay clearly conﬁrmed the pres-
ence of two X chromosome copies in all samples except one
that was known from karyotype analysis to have four X chro-
mosomes. Based on the results of the two methods used,
Turner samples were divided into two groups: 13 samples
lacking heterozygosity at all six SNPs and 8 samples that
are heterozygous at least at one of the six studied loci. From
the latter group, the TaqMan copy number assay showed
two samples, to be mosaic for the presence of an additional
X chromosome, while the rest are supposed to have a
normal female karyotype (Supplementary Material, Table S5).
The ﬁbroblastoid and lymphoblastoid cell lines were also
tested with the TaqMan-based copy number assay for the
expected X chromosome numbers. All four ﬁbroblastoid lines
showstheexpectedXcopynumbers.However,thelymphoblas-
toid cell lines with the expected 4X (375-99 LCL) and 5X
(377-99 LCL) showed a considerable decrease from the
expected X chromosome numbers with 3.25 and 4.12 predicted
X copy numbers (Supplementary Material, Table S5). This
couldbeduetorecombinationeventsoccurringduringdifferent
passagingincellcultureortoadecreaseinsensitivityoftheused
assaywithincreasingcopynumberoftargetsequences.Itwould
require much larger numbers of replicates to achieve accurate
copy numbers determination as previously suggested (50).
However, we assumed that the quantitative TaqMan-based
assay is reﬂecting the true X chromosome copy number.
In summary, the samples in this study include peripheral
blood samples from 13 Turner syndrome patients (45,X), 28
men (46,XY), 28 women (46,XX) and 39 Klinefelter syn-
drome patients (47,XXY). Moreover, one Klinefelter sample
with 49,XXXXY karyotype was also available. In addition,
10 lymphoblastoid and 3 ﬁbroblastoid cell lines were included
in the study.
Exclusion of C to T polymorphisms at the investigated
autosomal CpG sites
Since C to T polymorphisms are common at CpG sites, such C
to T changes would be detected after bisulﬁte as non-
methylated cytosine, thus interfering with the average methy-
lation values of CpG sites. To exclude this inﬂuence, we
sequenced three autosomal regions (C2Hs, C10Hs, C11Hs)
in all studied samples from non-bisulﬁte-treated DNA. No
detectable C to T transition was found in any of the
samples. As individual methylation values at other regions
do not harbor considerable variations .50% (which could
be an indication for the presence of a C to T polymorphism),
we assumed that all of the CpG sites included in this study are
not overlapping with polymorphisms that could interfere with
the quantitative methylation data.
Methylation analysis
Bisulﬁte modiﬁcations and ampliﬁcation of speciﬁc repeats.
About 1000 ng input DNA was used for the bisulﬁte conver-
sion; this was done using the EZ DNA Methylation-Gold
Kit (Zymo Research, Orange, CA, USA) according to the
manufacturer’s protocol. To minimize assay variability or
batch variability, we distributed the different samples of the
Turner, male, female and Klinefelter groups over two plates,
whereby each plate contained an approximately similar
number of samples from every group.
A semi-nested PCR approach was used to amplify speciﬁc
LINE-1 repeats. Primer sequences used for ampliﬁcations in
this study are listed in Supplementary Material, Table S6.
To select LINE-1 regions for ampliﬁcations, we used a Blat
search on the UCSC genome browser (http://genome.ucsc.
edu; 51) of the LINE-1 promoter region (L1Hs; NCBI acces-
sion number: X58075). We selected LINE-1 on autosomes that
were .6 kb in length, with the highest homology to the con-
sensus sequence, ﬂanked by a unique genomic DNA sequence
and covering the highest possible numbers of CpGs. Using this
strategy, we were able to speciﬁcally amplify ﬁve autosomal
LINE-1 (L1Hs) promoter regions with the highest homology
to the consensus sequence. We then localized all 25 L1Hs
on the X chromosome and were able to speciﬁcally amplify
15 of them, while the remaining 10 were either not ﬂanked
by unique DNA sequence or unable to verify their speciﬁc
ampliﬁcation and thus were discarded. Moreover, 14 L1M
and 22 L1P on the X chromosome were chosen to be
imbedded in genes or loci that are known either to be inacti-
vated or to escape inactivation. Therefore, we were able to
speciﬁcally amplify 8 L1M and 16 L1P loci. All PCR ampli-
ﬁcations were done using hot-start Taq polymerase (HOT
FIREPol from Solis BioDyne, Tartu, Estonia). The success
of locus-speciﬁc ampliﬁcation was conﬁrmed by direct
sequencing of each region (data not shown). In addition, we
targeted six X-linked CpG islands subject to X chromosome
inactivation, Information regarding their methylation levels
in male and female samples was established in our MeDIP
experiments on male and female peripheral blood-derived
DNA as previously reported (35).
Quantitative methylation analysis. Quantitative methylation at
speciﬁc CpG sites was done either by SIRPH protocol as pre-
viously described (52,53) or by pyrosequencing performed
according to Tost et al.( 54). The latter was performed using
Pyro Gold reagents from Biotage (Uppsala, Sweden) on a
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listed in Supplementary Material, Table S6.
Cloning and sequencing and calculation of methylation
entropy. Individual PCR products were cleaned using the QIA-
quick PCR puriﬁcation kit (order no. 28106; Qiagen). Next,
the puriﬁed PCR product was ligated to a pGEM-T cloning
vector (pGEM-T Vector System 1, order no. A3600,
Promega, Mannheim, Germany). Individual positive clones
were isolated by PCR using M13 primers and sequenced
using ABI standard protocols. The methylation entropy that
reﬂects on the allelic or non-allelic distribution of methylation
at a given locus was calculated according to Xie et al.( 55). A
sliding window of four CpGs was used at one time, and next,
the average of all windows was used as an estimate of the
methylation entropy in a given sample at a given region.
Global genomic methylation contents by the LUMA method
(methylation levels at CCGG sites). Luminescence methyla-
tion assay (LUMA) was essentially performed as previously
described by Karimi et al.( 56). Brieﬂy, 500 ng of DNA to
be measured was cleaved with HpaII + EcoR1 or MspI +
EcoR1 (ﬁve units from each enzyme) in two separate tubes.
The total volume of reaction was 20 ml. The tubes were incu-
bated at 378C for exactly 4 h. Next, 20 ml annealing buffer
(20 mM Tris-acetate, 2 mM Mg-acetate pH 7.6) was added
and samples were measured in a PSQ96TM MA pyrosequen-
cing machine (Biotage AB). EcoR1 leaves 5′-TTAA sticky
ends on the DNA that can be extended by As and Ts, while
HpaII and MspI leaves 5′-GC that can be extended by Cs
and Gs. Therefore, the machine was programmed to add As,
next Gs and Cs. The ﬁrst would generate peaks corresponding
to the EcoRI digestion, which can be used as internal control
for the quantity of DNA and the efﬁciency of cleavages, while
the second would give peaks corresponding to all CCGG sites
(for MspI) or for the unmethylated portion of CCGG (for
HpaII). Next, the percentage of methylated CCGG sites was
calculated according to the formula: Meth% ¼ [1-(peak
HpaII/peak EcoRI)/(peak MspI/peak EcoRI)]∗100.
Statistical analysis
T-test and Bonferroni–Holmes corrections. T-test was applied
to investigate at a speciﬁc CpG site whether the methylation
levels between two groups (Turner, male, female and Klinefel-
ter samples, each two at a time) are signiﬁcantly different. The
Bonferroni–Holmes correction was applied to correct for
multiple testing.
Correlation between different CpG sites within one group.T o
investigate a possible correlation between different CpG sites
within one studied locus and across different loci in one group
of individuals with the same karyotypes, we applied Pearson
correlation followed by Bonferroni–Holmes correction for
multiple testing.
Statistical signiﬁcance of sequencing data was assesses by
the non-parametric Wilcoxon test. Comparison of the two
groups, the ﬁrst derived from 45,X and 46,XY (one active
X) and the second included the clones derived from 46,XX
and 47,XXY (containing active and inactive X), at each of
the six loci was performed.
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG online.
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